ClinicalTrials.gov
ClinicalTrials.gov Menu

Ziprasidone in the Treatment of Borderline Personality Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00635921
Recruitment Status : Completed
First Posted : March 14, 2008
Last Update Posted : March 14, 2008
Sponsor:
Collaborators:
Ministry of Health, Spain
REM-TAP Network
Pfizer
Information provided by:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2006
  Actual Study Completion Date : April 2006

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 28, 2011
February 24, 2011
2 January 21, 2013
February 22, 2013